2023 VISION Registry Data Report

At the time of diagnosis and with metastatic ocular melanoma did the patient utilize support services? How did this vary by country and region of residence? 32 responses 9% Unknown I. The Patient Journey Personal Profile/Metastasis Diagnosis

The 24% of patients who responded “Yes” reported:

Country of residence:

12% Canada

88% United States (7 responses) US region:

(1 response)

The 9% of patients who responded “Unknown” reported:

12% Not offered

Country of residence: 33% Norway (1 response) 67% United States (2 responses)

43% West

(3 responses)

57% Southeast

24% Yes

(4 responses)

US region:

67% Southeast

(2 responses)

33% Midwest

52% No

(1 response)

The 52% of patients who responded “No” reported:

6% Canada (1 response) 94% United States (16 responses) Country of residence:

The 12% of patients who responded “Not offered” reported:

Country of residence:

US region:

25% Canada

50% United States (2 responses)

25% West

38% Southeast

(1 response)

(4 responses)

(6 responses)

25% Slovenia

US region:

6% Southwest (1 response) 13% Midwest (2 responses)

18% Northeast

(1 response)

(3 responses)

100% West

(2 responses)

2023 VISION Registry Data Report

28

Made with FlippingBook Ebook Creator